#India #Clinical Trials #Ahmedabad #Veeda Lifesciences #Biopharma Services

Veeda Group Rebrands as Veeda Lifesciences

In an ambitious move signaling a shift towards a more integrated approach in drug development services, Veeda Group has rebranded itself as Veeda Lifesciences. This rebranding, which comes with a fresh logo and overall brand identity, marks a pivotal point in the company’s journey, transitioning from its origins as a generics-focused Contract Research Organization (CRO) to a more expansive enterprise catering to various modalities of drug development, including both generics and innovative chemical and biological entities.

A Strategic Transition

The newly adopted identity of Veeda Lifesciences reflects the company’s evolution and highlights its commitment to innovation. As outlined by Dr. Mahesh Bhalgat, the Group CEO and Managing Director, the new brand not only symbolizes a modern and dynamic outlook but also serves as motivation for future aspirations. The transition from generics to innovations showcases Veeda’s broader ambitions as it diversifies its service offerings to meet the growing needs of clients in the life sciences sector.

Veeda Lifesciences is now organized into four distinct Strategic Business Units:
1. Clinical Trials
2. Healthy Volunteer Services
3. Biopharma Services
4. Preclinical Non-Clinical Testing Services

This restructuring is aimed at positioning Veeda as an integrated research service provider, encompassing all stages of drug development. The company aims to connect various capacities across these units, ensuring a seamless delivery of services that span the entire drug development value chain.

Comprehensive Research Services

The rebranded Veeda Lifesciences platform integrates several existing entities, such as Veeda Clinical Research, Health Data Specialists, and Bioneeds India. This consolidation enables the company to offer a comprehensive range of research services that cater to different phases of drug development - from discovery and preclinical stages to late-phase clinical trials.

The organization is gearing up to adopt a CRO-CDMO model—a dual focus on Contract Research Organization services while also integrating Contract Development and Manufacturing Organization capabilities. This evolution is further bolstered through the effective use of AI and real-world data—a key factor that positions Veeda Lifesciences at the forefront of modern drug development methodologies.

Global Presence and Commitment to Innovation

Founded in 2004 in India, Veeda Lifesciences has grown exponentially, with operations extending to five countries and conducting clinical trials in 26 geographies worldwide. The strategic acquisition of Bioneeds in 2021 marked a substantial expansion into preclinical services, enhancing Veeda’s capacity to cater to the diverse needs of the healthcare and life sciences industries.

Today, Veeda offers a broad spectrum of services not only to local pharmaceutical companies but also to leading global pharma players, thereby solidifying its role as a trusted partner in drug development processes.

The four Strategic Business Units provide specialized services, including:

• - Clinical Trials: Operations that are now based in Europe, which initially catered solely to clinical research, have been expanded to include patient-based clinical trials in India.
• - Healthy Volunteer Services: Based in Gujarat, India, this arm specializes in clinical bioanalysis for small molecules.
• - Biopharma Services: Located in Bengaluru, this unit focuses on analytical and functional characterization of biologics in addition to cell line development and clinical bioanalysis for large molecules.
• - Preclinical Testing Services: Situated in Karnataka, it emphasizes discovery research in both chemistry and biology, proving vital to the early stages of drug development.

Conclusion

As Veeda Lifesciences makes these bold moves, it reflects a commitment to not just serving the industry but leading it towards a future where innovative therapies and generic drugs can be developed more efficiently and effectively. The firm continues to prioritize investments in both personnel and technology to ensure it remains aligned with the fast-evolving landscape of the life sciences sector.

With its rebranding, Veeda Lifesciences stands ready to tackle tomorrow's challenges while also meeting the current demands of the global healthcare community.

The newly designed logo and vibrant identity fittingly represent the vision and mission of this forward-thinking company, heralding an era of growth and excellence that prioritizes client satisfaction and innovative solutions in drug development.